CommercialBilling CodesMedium impact
07.13.05m, Photodynamic Therapy (PDT) Using Verteporfin (Visudyne®)
Independence Blue Cross·Ophthalmology, Oncology, Pharmacy·Pharmacy
Effective date
Nov 17, 2025
We identified it
Jun 19, 2026
Summary
This is a medical coding and informational update to policy 07.13.05m regarding Photodynamic Therapy (PDT) using Verteporfin (Visudyne®). The policy was posted on 11/17/2025 with an effective date of 11/17/2025. However, the provided content does not include the specific details of what changed in the policy, only metadata indicating it is a General Description, Guidelines, or Informational Update.
Action Required
By 11/17/2025: Billing team must review the complete policy text at https://medpolicy.ibx.com/ibc/Commercial/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=11&FilterField2=MPSiteActivityLogYear&FilterValue2=2025#commercial-07-13-05m to identify specific CPT, HCPCS, and ICD-10 codes affected by this medical coding update. Once specific codes are identified, update billing software, encounter forms, and provider documentation guidelines as needed. Ensure providers are notified of any changes to Verteporfin (Visudyne®) coding or billing requirements. Document all changes in the compliance tracking system.